Pfizer: Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor and the transformative COVID-19 vaccine Comirnaty, developed with BioNTech (NASDAQ:BNTX), Pfizer has shaped healthcare for decades. Its $43 billion acquisition of Seagen in 2023 [...]The post Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030 appeared first on 24/7 Wall St..